blood clots and glp 1 GLP-1 RA's Increase Clot Risks Can Weight Loss Injections Cause
Description
GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.
Administered as a subcutaneous weekly injection, it is a manifold single pharmacological agent that has the ability to significantly lower glucose levels, as well as improve insulin sensitivity, reduce weight and amend dyslipidemia favorably modifying the lipid profile
It is a predictable physiological reality of significant weight loss: as the body's overall mass decreases, it requires less structural support and energy
No doctor
The natural way to support GLP-1 production
